IMNN
Price
$0.83
Change
+$0.01 (+1.22%)
Updated
May 8 closing price
Capitalization
11.99M
3 days until earnings call
MLTX
Price
$39.74
Change
+$2.14 (+5.69%)
Updated
May 8 closing price
Capitalization
2.39B
90 days until earnings call
Ad is loading...

IMNN vs MLTX

Header iconIMNN vs MLTX Comparison
Open Charts IMNN vs MLTXBanner chart's image
Imunon
Price$0.83
Change+$0.01 (+1.22%)
Volume$51.88K
Capitalization11.99M
MoonLake Immunotherapeutics
Price$39.74
Change+$2.14 (+5.69%)
Volume$745.32K
Capitalization2.39B
IMNN vs MLTX Comparison Chart
Loading...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNN vs. MLTX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNN is a Hold and MLTX is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (IMNN: $0.83 vs. MLTX: $39.74)
Brand notoriety: IMNN and MLTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNN: 52% vs. MLTX: 159%
Market capitalization -- IMNN: $11.99M vs. MLTX: $2.39B
IMNN [@Biotechnology] is valued at $11.99M. MLTX’s [@Biotechnology] market capitalization is $2.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNN’s FA Score shows that 0 FA rating(s) are green whileMLTX’s FA Score has 0 green FA rating(s).

  • IMNN’s FA Score: 0 green, 5 red.
  • MLTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMNN and MLTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNN’s TA Score shows that 4 TA indicator(s) are bullish while MLTX’s TA Score has 9 bullish TA indicator(s).

  • IMNN’s TA Score: 4 bullish, 5 bearish.
  • MLTX’s TA Score: 9 bullish, 1 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than IMNN.

Price Growth

IMNN (@Biotechnology) experienced а -0.60% price change this week, while MLTX (@Biotechnology) price change was -4.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

IMNN is expected to report earnings on Aug 13, 2025.

MLTX is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MLTX($2.39B) has a higher market cap than IMNN($12M). IMNN YTD gains are higher at: -12.105 vs. MLTX (-26.611). IMNN has higher annual earnings (EBITDA): -17.9M vs. MLTX (-141.71M). MLTX has more cash in the bank: 448M vs. IMNN (5.87M). IMNN has less debt than MLTX: IMNN (1.14M) vs MLTX (2.83M). IMNN (0) and MLTX (0) have equivalent revenues.
IMNNMLTXIMNN / MLTX
Capitalization12M2.39B1%
EBITDA-17.9M-141.71M13%
Gain YTD-12.105-26.61145%
P/E RatioN/AN/A-
Revenue00-
Total Cash5.87M448M1%
Total Debt1.14M2.83M40%
FUNDAMENTALS RATINGS
IMNN: Fundamental Ratings
IMNN
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNNMLTX
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
70%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
65%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 1 day ago
63%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
58%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 25 days ago
76%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
73%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 1 day ago
79%
View a ticker or compare two or three
Ad is loading...
IMNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CHTVX20.76N/A
N/A
Invesco Charter R5
FBGKX203.58N/A
N/A
Fidelity Blue Chip Growth K
DNLAX37.22N/A
N/A
BNY Mellon Natural Resources A
BQMGX23.84N/A
N/A
Bright Rock Mid Cap Growth Instl
EQIDX12.38N/A
N/A
Allspring Emerging Markets Eq Advtg Adm

IMNN and

Correlation & Price change

A.I.dvisor tells us that IMNN and PCSA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMNN and PCSA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNN
1D Price
Change %
IMNN100%
+1.84%
PCSA - IMNN
32%
Poorly correlated
+6.37%
STOK - IMNN
30%
Poorly correlated
+4.50%
DNLI - IMNN
30%
Poorly correlated
+0.77%
DTIL - IMNN
29%
Poorly correlated
-0.58%
IVVD - IMNN
28%
Poorly correlated
+0.82%
More